Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Polyps × Fatty Acids, Omega-3 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 15 Prostatic Neoplasms 4 Neoplasms 4 Carcinoma, Intraductal, Noninfiltrating 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Precancerous Conditions 2 Peripheral Nervous System Diseases 2 Pain 2 Colonic Neoplasms 2 Cardiovascular Diseases 2 Breast Carcinoma In Situ 2 Arthralgia 2 Weight Loss 1 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Smoldering Multiple Myeloma 1 Radiation Injuries 1 Psoriasis 1 Polyps 1 Polycystic Ovary Syndrome 1 Pelvic Inflammatory Disease 1 Ovarian Neoplasms 1 Osteoarthritis 1 Neoplasms, Plasma Cell 1 Multiple Myeloma 1 Monoclonal Gammopathy of Undetermined Significance 1 Malnutrition 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1

Interventions

Colonoscopy 7 Endoscopy 3 Narrow Band Imaging 2 Eicosapentaenoic Acid 2 eicosapentaenoic acid ethyl ester 1 Uterine Myomectomy 1 Ursodeoxycholic Acid 1 Telemedicine 1 Sennosides 1 Selenium 1 Restraint, Physical 1 Radiotherapy 1 Propofol 1 Polyethylene Glycols 1 Ofloxacin 1 Midazolam 1 Metoclopramide 1 Methods 1 Folic Acid 1 Fentanyl 1 Fatty Acids, Omega-3 1 Everolimus 1 Erythromycin 1 Endoscopic Mucosal Resection 1 Endomet 1 Doxycycline 1 Docosahexaenoic Acids 1 Diet, Fat-Restricted 1 Diatrizoate Meglumine 1 Diagnosis 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03661047 2021-11-17

OMICC

Massachusetts General Hospital

Phase 2 Withdrawn

Gastrointestinal

Colonic Neoplasms, Polyps, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡